Extracellular matrix turnover in salivary gland disorders and regenerative therapies: Obstacles and opportunities
- PMID: 37719063
- PMCID: PMC10502366
- DOI: 10.1016/j.jobcr.2023.08.009
Extracellular matrix turnover in salivary gland disorders and regenerative therapies: Obstacles and opportunities
Abstract
Salivary gland (SG) extracellular matrix (ECM) has a major influence on tissue development, homeostasis, and tissue regeneration after injury. During aging, disease, and physical insult, normal remodeling of the SG microenvironment (i.e. ECM) becomes dysregulated, leading to alterations in matrix composition which disrupt tissue architecture/structure, alter cell activity, and negatively impact gland function. Matrix metalloproteinases (MMPs) are a large and diverse family of metalloendopeptidases which play a major role in matrix degradation and are intimately involved in regulating development and cell function; dysregulation of these enzymes leads to the production of a fibrotic matrix. In the SG this altered fibrotic ECM (or cell microenvironment) negatively impacts normal cell function and the effectiveness of gene and stem cell therapies which serve as a foundation for many SG regenerative therapies. For this reason, prospective regenerative strategies should prioritize the maintenance and/or restoration of a healthy SG ECM. Mesenchymal stem cells (MSCs) have great potential for mitigating damage to the SG microenvironment by ameliorating inflammation, reducing fibrosis, and repairing the damaged milieu of extracellular regulatory cues, including the matrix. This review addresses our current understanding of the impact of aging and disease on the SG microenvironment and suggests critical deficiencies and opportunities in ECM-targeted therapeutic interventions.
Keywords: Aging; Extracellular matrix; Fibrosis; Matrix metalloproteinases; Salivary gland; Tissue remodeling.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Chen is a Board member and shareholder in StemBioSys, Inc. (San Antonio, TX). Dr. Marinkovic is a shareholder and member of the Scientific Advisory Board of StemBioSys, Inc. (San Antonio, TX). All other authors have no financial or competing interests to declare.
Figures




Similar articles
-
Injectable decellularized extracellular matrix hydrogel promotes salivary gland regeneration via endogenous stem cell recruitment and suppression of fibrogenesis.Acta Biomater. 2023 Oct 1;169:256-272. doi: 10.1016/j.actbio.2023.08.003. Epub 2023 Aug 7. Acta Biomater. 2023. PMID: 37557943
-
Organ-specific extracellular matrix directs trans-differentiation of mesenchymal stem cells and formation of salivary gland-like organoids in vivo.Stem Cell Res Ther. 2022 Jul 15;13(1):306. doi: 10.1186/s13287-022-02993-y. Stem Cell Res Ther. 2022. PMID: 35841112 Free PMC article.
-
Three-Dimensional Culture of Salivary Gland Stem Cell in Orthotropic Decellularized Extracellular Matrix Hydrogels.Tissue Eng Part A. 2019 Oct;25(19-20):1396-1403. doi: 10.1089/ten.TEA.2018.0308. Epub 2019 Mar 18. Tissue Eng Part A. 2019. PMID: 30632466
-
Development of Matrix Metalloproteinases-Mediated Extracellular Matrix Remodeling in Regenerative Medicine: A Mini Review.Tissue Eng Regen Med. 2023 Aug;20(5):661-670. doi: 10.1007/s13770-023-00536-x. Epub 2023 May 9. Tissue Eng Regen Med. 2023. PMID: 37160567 Free PMC article. Review.
-
Autologous mesenchymal stem cells offer a new paradigm for salivary gland regeneration.Int J Oral Sci. 2023 May 10;15(1):18. doi: 10.1038/s41368-023-00224-5. Int J Oral Sci. 2023. PMID: 37165024 Free PMC article. Review.
Cited by
-
The Mayo Clinic Salivary Tissue-Organoid Biobanking: A Resource for Salivary Regeneration Research.bioRxiv [Preprint]. 2024 Feb 27:2024.02.23.581761. doi: 10.1101/2024.02.23.581761. bioRxiv. 2024. PMID: 38464033 Free PMC article. Preprint.
-
Establishment of salivary tissue-organoid biorepository: characterizing salivary gland stem/progenitor cells and novel differentiation marker PSMA/FOLH1.NPJ Regen Med. 2025 May 21;10(1):23. doi: 10.1038/s41536-025-00410-5. NPJ Regen Med. 2025. PMID: 40399315 Free PMC article.
-
Immune and non-immune mediators in the fibrosis pathogenesis of salivary gland in Sjögren's syndrome.Front Immunol. 2024 Oct 14;15:1421436. doi: 10.3389/fimmu.2024.1421436. eCollection 2024. Front Immunol. 2024. PMID: 39469708 Free PMC article. Review.
-
Impaired salivary gland function in children with osteogenesis imperfecta: a case-control study.Clin Oral Investig. 2024 Dec 13;29(1):14. doi: 10.1007/s00784-024-06100-8. Clin Oral Investig. 2024. PMID: 39671080
-
Senescence and fibrosis in salivary gland aging and disease.J Oral Biol Craniofac Res. 2024 May-Jun;14(3):231-237. doi: 10.1016/j.jobcr.2024.02.009. Epub 2024 Mar 13. J Oral Biol Craniofac Res. 2024. PMID: 38516126 Free PMC article.
References
-
- Marinkovic M., Dean D.D., Chen X.D. In: A Roadmap to Non-hematopoietic Stem Cell-Based Therapeutics. Chen X.-D., editor. Academic Press; 2019. Maintenance and culture of MSCs; pp. 39–61. Published online 2019. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources